Celgene Corp (NASDAQ:CELG)

93.76
Delayed Data
As of Apr 18
 -0.54 / -0.57%
Today’s Change
58.59
Today|||52-Week Range
95.44
+46.29%
Year-to-Date
How Marijuana Legalization Affected OrganiGram and Aphria's Latest Results
Apr 20 / MotleyFool.com - Paid Partner Content
Financial Advantage, Inc. Buys The Walt Disney Co, Celgene Corp, Bristol-Myers Squibb...
Apr 17 / GuruFocus News - Paid Partner Content
Top Gene-Sequencing Stocks for 2019
Apr 19 / MotleyFool.com - Paid Partner Content
Stralem & Co Inc Buys Cisco Systems Inc, Progressive Corp, Sells Chubb, Celgene Corp,...
Apr 17 / GuruFocus News - Paid Partner Content
5 Top Biotech Stocks to Buy in 2019
Apr 19 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: GILD Collaborates on NASH, FCSC Surges on Deal
Apr 17 / Zacks.com - Paid Partner Content
5 Top Healthcare Stocks to Buy in 2019
Apr 19 / MotleyFool.com - Paid Partner Content
Is TG Therapeutics a Buy?
Apr 16 / MotleyFool.com - Paid Partner Content
Bowling Portfolio Management LLC Buys Celgene Corp, Jazz Pharmaceuticals PLC, CBRE Gr...
Apr 18 / GuruFocus News - Paid Partner Content
Why Celgene Shareholders Should Hold On to Their Bristol-Myers Squibb Stock Once the ...
Apr 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close94.30
Today’s open94.67
Day’s range93.32 - 94.69
Volume10,590,794
Average volume (3 months)10,938,680
Market cap--
Data as of 4:00pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)+49.83%
Earnings growth (this year)+20.71%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+19.26%
P/E ratio17.0
Price/Sales3.08
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.28-0.61%
TAKTakeda Pharmaceutica...-0.33-1.79%
ZTSZoetis Inc+1.05+1.07%
AGNAllergan+0.28+0.20%
Data as of 4:03pm ET, 04/18/2019

Financials

Next reporting dateMay 6, 2019
EPS forecast (this quarter)$2.45
Annual revenue (last year)$15.3B
Annual profit (last year)$4.0B
Net profit margin26.46%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
COO
Mark J. Alles
CFO, Principal Accounting Officer &
Executive VP
David V. Elkins
Corporate headquarters
Summit, New Jersey

Forecasts